IP Library Granted Patent US 11,464,902
Granted Patent B1
US 11,464,902 · App. 17/178,795 · Granted Oct 11, 2022

Wearable medicament delivery device with compressible reservoir and method of use thereof

Inventors: David R. Schiff (Highland Park, NJ); Sharon D. West (Elkins Park, PA); Jason Zerweck (Media, PA)
Assignee: Fresenius Kabi Deutschland GmbH
A61M5/14248A61M5/148A61M5/1454A61M5/16881A61M5/152A61M2005/14204A61M2005/14506A61M2205/8281
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,464,902
App. No.
17/178,795
Granted
Oct 11, 2022
Kind
B1
Abstract

A wearable drug delivery device and related methods are described. The wearable drug delivery device can include: a housing; a flexible bag disposed within the housing; a cannula in fluid communication with the flexible bag; and a pumping mechanism for forcing a drug from the flexible bag and into the cannula, wherein the pumping mechanism is proximate the flexible bag and includes a spring-loaded paddle or a driving bag.

Claims (32)

1. A wearable drug delivery device comprising:

a housing;

a flexible bag disposed within the housing;

a cannula in fluidic communication with the flexible bag, the cannula comprising:

a proximal end connected to the flexible bag; and

a distal end that exits the housing;

a support disposed between the flexible bag and at least a portion of the cannula;

a pumping mechanism for forcing a drug from the flexible bag and into the cannula, the pumping mechanism proximate the flexible bag and comprising a spring-loaded paddle,

wherein the spring-loaded paddle comprises a hinged connection, and

wherein the flexible bag is compressed between the support and the spring-loaded paddle; and

a valve positioned inside the housing and between the proximal end of the cannula and the distal end of the cannula,

wherein the valve is configured to open and close to control a flow of the drug through the cannula.

2. The device of claim 1 , wherein the spring-loaded paddle is driven by a torsion spring or a compression spring.

3. The device of claim 1 , wherein the housing comprises at least one of: a flexible outer shell or a housing height less than 12 mm.

4. The device of claim 1 , wherein the valve is configured to crimp or squeeze the cannula.

5. A method of delivering a drug, the method comprising:

providing a wearable drug delivery device comprising:

a housing;

a flexible bag disposed within the housing;

a cannula in fluidic communication with the flexible bag, the cannula comprising:

a proximal end connected to the flexible bag; and

a distal end that exits the housing;

a support disposed between the flexible bag and at least a portion of the cannula;

a valve positioned inside the housing and between the proximal end of the cannula and the distal end of the cannula; and

a pumping mechanism comprising a spring-loaded paddle, wherein the spring-loaded paddle comprises a hinged connection;

activating the pumping mechanism to force a drug from the flexible bag and into the cannula, wherein the flexible bag is compressed between the support and the spring-loaded paddle; and

opening and closing the valve to control a flow of the drug through the cannula.

6. The method of claim 5 , wherein the step of activating the pumping mechanism comprises pivoting the spring-loaded paddle about the hinged connection.

7. The method of claim 6 , wherein the step of pivoting the spring-loaded paddle comprises driving the spring-loaded paddle with a torsion spring or a compression spring.

8. The method of claim 5 , wherein the housing comprises at least one of: a flexible outer shell or a housing height less than 12 mm.

9. The method of claim 5 , wherein the step of opening and closing the valve comprises crimping or squeezing the cannula.

10. The method of claim 5 , wherein the drug comprises pegfilgrastim.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT NAME IS FRESENIUS KABI DEUTSCHLAND GMBH PREVIOUSLY RECORDED AT REEL: 055639 FRAME: 0544. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 8, 2022
From: BRESSLERGROUP, INC.
To: FRESENIUS KABI DEUTSCHLAND GMBH
Reel/Frame 059644/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: BRESSLERGROUP, INC.
To: FRESENIUS KABI DEUTCHLAND GMBH
Reel/Frame 055639/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2021
From: SCHIFF, DAVID R.; WEST, SHARON D.; ZERWECK, JASON
To: BRESSLERGROUP, INC.
Reel/Frame 055591/0969 →
Cited By (1)
US 12,447,270